Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$9.10 +0.79 (+9.51%)
At close: Sep 30, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Cash from Operations (2023 - 2025)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Cash from Operations of -$9.73 million in the quarter ended Dec 31, 2025, compared with -$5.97 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Cash from Operations (2023 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals reported Cash from Operations of -$28.55 million.

  • Across earlier years, Cash from Operations came in at -$29.99 million in the year ended Dec 31, 2024, -$20.75 million in the year ended Dec 31, 2023 and -$14.4 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 Eupraxia Pharmaceuticals 363.60 Mn 362.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -9.73 Mn
Dec 31, 2024 -5.97 Mn
Dec 31, 2023 -5.96 Mn
Sep 30, 2023 -5.94 Mn
API Access

Eupraxia Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=EPRX&period=max&api_key=YOUR_API_KEY